Cite
HARVARD Citation
Alba, E. et al. (2013). Cost–utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain. Expert review of pharmacoeconomics & outcomes research. pp. 381-391. [Online].